Welcoming Four New Postdoctoral Researchers to the CRUK City of London Radiation Research Centre
The CRUK City of London Radiation Research Centre is delighted to welcome four outstanding postdoctoral researchers who are joining us to advance the centre’s vital scientific goals. Their arrival marks an exciting period of growth and reflects our commitment to nurturing the next generation of leaders in radiation science. Each brings unique expertise that will strengthen our collaborative research community, and we look forward to the discoveries their work will help drive.
Dr Marti Brucoli – Queen Mary University of London
Dr Marti Brucoli joins the centre at Queen Mary University of London, where he will work with Dr Luigi Ombrato to identify immune cell subpopulations and molecular signatures associated with metastasis formation. His research aims to deepen understanding of how metastatic tumours develop and spread. Marti completed his PhD in Cancer Studies at the University of Glasgow.
Dr Harriet Roddy – University College London (UCL)
Based at UCL, Dr Harriet Roddy will work with Dr Claire Roddie to investigate how combining CAR T cell therapy with radiotherapy could improve outcomes in solid tumours. Her work explores an emerging therapeutic frontier with significant potential for clinical impact. Harriet received her PhD in Cancer Immunotherapy from UCL.
Dr George Firth – King’s College London (KCL)
Dr George Firth joins King’s College London to work with Dr Cinzia Imberti on uncovering new mechanisms of radiation resistance. His research focuses on the role of intracellular manganese (Mn)—an essential cofactor of the enzyme superoxide dismutase—in driving antioxidant capacity within cells. George completed his PhD in Medical Imaging Sciences and Biomedical Engineering at KCL.
Dr Isaline Renard – King’s College London (KCL)
Also based at KCL, Dr Isaline Renard will work with Professor Stephen Archibald to develop and evaluate novel radiopharmaceutical platforms for cancer imaging and targeted molecular radiotherapy. Her work will contribute to advancing precision tools for diagnosis and treatment.
